Performance of a novel spectroscopy-based tool for adjuvant therapy decision-making in hormone receptor-positive breast cancer: a validation study.

R Charles CoombesChristina AngelouZamzam Al-KhaliliWilliam HartDarius FrancescattiNicholas WrightIan EllisAndrew GreenEmad RakhaSami ShoushaHemmel AmraniaChris C PhillipsCarlo Palmieri

Published in: Breast cancer research and treatment (2024)

DPS showed high accuracy and predictive performance, was able to stratify patients into low or high-risk, and considering its cost and rapidity, has the potential to offer clinical utility.

Keyphrases

positive breast cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
high resolution
single molecule
mass spectrometry
patient reported